Home > Press > A Nanobiotechnology Startup from a small town in India attracts the Global Investors
Abstract:
Ariviya, a Nanotechnology Biotechnology Startup from a small town Pattukkottai in the State of Tamil Nadu, India who is developing a product called MammaryO to prevent a costly disease "Mastitis" in dairy cows at big dairy farms, attracts global investors in Tamil Nadu Global Investor Meet 2019.
Bovine mastitis is the costliest problem for dairy farmers all over the world. Annual loss due to Mastitis is 2 Billion USD in the US, 1.5 billion USD in Europe and 2.2 billion USD in India. Mastitis reduces milk production in the US by 11% and in India by 21%. Mastitis causes 70% of all avoidable losses during milk production. Mastitis is ranked second after infertility as the main reason for culling(slaughtering) cows. 20-50% of dairy cows treated for Mastitis in Europe and the USA.
Dr. Siva, Chief Technology Officer of Ariviya, said: "MammaryO is a natural, organic, thick Nano-Bio liquid foam covering and protecting the cow teats from bacterial infection and reduces the spread of organism which may cause Bovine Mastitis, lasts long enough in the cow teat until next milking, easily washable and biodegradable."
"The price per gallon goes up if you have less number of SCC(Somatic Cell Count) in your milk, but if your cow has Mastitis then this SCC number goes up, and price per gallon comes down. Preventing Mastitis means, doing business" said a seasoned dairy farm owner at Hyderabad, Telangana, India.
Current mastitis treatment is very inefficient. Mastitis is detected from visible swelling, abnormal milk, and rise in somatic cell count. Sick cows get separated from the rest of the cows for weeks then they undergo antibiotic treatment. For a long period, the cow can’t be milked because the antibiotics are unsafe for human consumption.
“Global investors see the value in what we are doing, the science behind our product, market size, demand and shows interest in joining us to scale our product to the next level," said Dr. Siva.
The Startup scene in the third tier cities and small towns are changing very fast, a lot of innovations happening here which can address the real problems. The founders of these small town Startups have a background which helps them to understand the problem deep and fast. Dr. Siva itself from the dairy farming family background but did his Ph.D. and researches in Singapore and Japan before founding Ariviya in his home town in India, no wonder how these small towns Startup attracts global investors.
####
About Ariviya Inc.
Arivya is inventing Nanobiotechnology solutions for problems in human wellness, animal wellness, agriculture, infrastructures. For example, Bovine Mastitis, Wound healing, Seed protection, Second-degree burn, Water purification, Seed coating, etc. At Ariviya we apply Lean methodology in technical research, product development, and commercialization.
For more information, please click here
Contacts:
Ganesh
Phone: +917010105831
Fax: 614602
Ariviya Inc
80/73 Chinnaiya St, Pattukkottai, Thanjavur, Tamil Nadu, India, 614602
Email :
Phone : +91 63827 81414
www.Ariviya.com
www.facebook.com/AriviyaLabs
www.twitter.com/AriviyaLabs
Copyright © Ariviya Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Food/Agriculture/Supplements
Silver nanoparticles: guaranteeing antimicrobial safe-tea November 17th, 2023
Night-time radiative warming using the atmosphere November 17th, 2023
DGIST and New Life Group launched a research project on "Functional beauty and health products using the latest nanotechnology" May 12th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||